IN8BIO INC's ticker is and the CUSIP is 45674E109. A total of 15 filers reported holding IN8BIO INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PRECEPT MANAGEMENT LLC | 50,000 | $101,000 | 0.72% |
| Voss Capital, LLC | 375,570 | $759,000 | 0.22% |
| Stonegate Investment Group, LLC | 232,310 | $469,000 | 0.02% |
| Sigma Planning Corp | 98,750 | $199,000 | 0.01% |
| Warberg Asset Management LLC | 15,000 | $30,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 74,000 | $149,000 | 0.00% |
| United Asset Strategies, Inc. | 14,000 | $28,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 52,347 | $105,000 | 0.00% |
| MORGAN STANLEY | 1,513 | $3,000 | 0.00% |
| BlackRock Inc. | 23,354 | $47,000 | 0.00% |